Google Deepmind shifts genomics AI from bulk tissue predictions to single cell type resolution with AlphaGenome 2

Google Deepmind has unveiled AlphaGenome 2, an AI model that analyzes genetic variants for individual cell types rather than across bulk tissue. Trained on more than 107 million cell profiles, it identifies nearly twice as many disease-relevant gene changes as its predecessor. The model is available for noncommercial research through an API and is set to be integrated into Google's agentic platform Antigravity.